Exploring Chemically Modified Short Activating RNAs to Increase Stability against Nucleases and Enhance Gene Activation

Short activating RNAs (saRNAs) are short duplex RNAs that activate genes in the nucleus of the cell. This induces gene activation, or RNA activation (RNAa), which upregulates gene expression. This activation is in direct contrast to short interfering RNAs (siRNAs), which downregulate gene expression through the activation of Argonaute 2 within the RNA-induced silencing complex (RISC). siRNA chemical modifications such as 2'-O-Me, 2'-F, locked nucleic acids (LNA), unlocked nucleic acids (UNA), and backbone modifications such as phosphorothioate (PS) have been well documented and studied. In this study, a library of chemically modified saRNAs was synthesized and evaluated for their ability to activate gene expression. We have identified that a thermally destabilizing abasic carbon-based linker within the central region of the sense strand, in conjunction with an affinity-enhancing nucleoside, LNA, on the antisense strand, offers optimal duplex melting temperature, nuclease stability, and enhanced gene activation.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-10-23
DOI
https://doi.org/10.1021/acs.jmedchem.5c01648
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring Chemically Modified Short Activating RNAs to Increase Stability against Nucleases and Enhance Gene Activation

Sara Aguti, Hannah M. Pendergraff, Jon Voutila, Jean‐Paul Desaulniers et al.
Journal of Medicinal Chemistry
RNA Interference and Gene Delivery
article

Exploring Chemically Modified Short Activating RNAs to Increase Stability against Nucleases and Enhance Gene Activation

Sara Aguti, Hannah M. Pendergraff, Jon Voutila, Jean‐Paul Desaulniers, Matthew L. Hammill, Troels Koch, Nagy Habib, Ifrodet Giorgees, H. Hansen, Yulia Lomonosova, Virginia Wing-Nam Chiu
article en

Abstract

Short activating RNAs (saRNAs) are short duplex RNAs that activate genes in the nucleus of the cell. This induces gene activation, or RNA activation (RNAa), which upregulates gene expression. This activation is in direct contrast to short interfering RNAs (siRNAs), which downregulate gene expression through the activation of Argonaute 2 within the RNA-induced silencing complex (RISC). siRNA chemical modifications such as 2'-O-Me, 2'-F, locked nucleic acids (LNA), unlocked nucleic acids (UNA), and backbone modifications such as phosphorothioate (PS) have been well documented and studied. In this study, a library of chemically modified saRNAs was synthesized and evaluated for their ability to activate gene expression. We have identified that a thermally destabilizing abasic carbon-based linker within the central region of the sense strand, in conjunction with an affinity-enhancing nucleoside, LNA, on the antisense strand, offers optimal duplex melting temperature, nuclease stability, and enhanced gene activation.

Journal of Medicinal ChemistryVol. 68(21)
Ontario Tech University (CA), Opexa Therapeutics (United States) (US)
Openalex Percentile: Top 73%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.